Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations
Authors
Keywords
-
Journal
STROKE
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-02-23
DOI
10.1161/strokeaha.120.029676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Could propranolol be beneficial in adult cerebral cavernous malformations?
- (2019) Caroline Apra et al. NEUROSURGICAL REVIEW
- Endothelial cell clonal expansion in the development of cerebral cavernous malformations
- (2019) Matteo Malinverno et al. Nature Communications
- Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy
- (2018) Jang-Hyuk Yun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells
- (2018) Matthew R. Detter et al. CIRCULATION RESEARCH
- Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations
- (2017) Romuald Girard et al. Translational Stroke Research
- Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease
- (2016) Romuald Girard et al. JOURNAL OF NEUROSCIENCE METHODS
- Propranolol stops progressive multiple cerebral cavernoma in an adult patient
- (2016) Matthias Reinhard et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition
- (2016) Luca Bravi et al. STROKE
- Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage
- (2016) Joseph M. Zabramski et al. World Neurosurgery
- KLF4 is a key determinant in the development and progression of cerebral cavernous malformations
- (2015) R. Cuttano et al. EMBO Molecular Medicine
- A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
- (2015) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes
- (2015) G. B. Schulz et al. STROKE
- Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation
- (2015) Naikhoba C.O. Munabi et al. Stem Cells Translational Medicine
- Pathogenesis of infantile haemangioma
- (2013) S. Greenberger et al. BRITISH JOURNAL OF DERMATOLOGY
- Diagnosis and Treatment of Vascular Malformations of the Brain
- (2013) Bradley A. Gross et al. Current Treatment Options in Neurology
- EndMT contributes to the onset and progression of cerebral cavernous malformations
- (2013) Luigi Maddaluno et al. NATURE
- Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice
- (2011) Gwénola Boulday et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now